Professor Stephen O’Rahilly (2007) will head up the new Metabolic Diseases Unit within the Wellcome Trust-Medical Research Council (MRC) Institute of Metabolic Science (IMS).
The Metabolic Diseases Unit (MDU) has been set up as part of a £24 million investment in Cambridge by the Wellcome Trust and the MRC to research the causes and health consequences of obesity.
Professor O’Rahilly is Co-Director of the Wellcome Trust-MRC IMS. He is also the Principal Investigator on an MRC Programme Grant focused on Molecular and Pathophysiological Mechanisms in Obesity.
More information on the £24 million grant can be found on the University’s website.